| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
73,830,000 |
| Market
Cap: |
3.79(B) |
| Last
Volume: |
480,476 |
Avg
Vol: |
694,871 |
| 52
Week Range: |
$39.75 - $67.51 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Semiconductor Equipment & Materials |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
NASDAQ COMPUTER |
|
S&P SMALLCAP 600 |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 443 |
| Guru Rank Value : 3.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Azenta provides life science sample exploration and management solutions. Co.'s segments are: Life Sciences Products, which provides automated cold sample management systems for compound and biological sample storage, equipment for sample preparation and handling, consumables, and instruments; and Life Sciences Services, which provides sample management programs, cold chain solutions, informatics, as well as sample-based laboratory services, including sample storage, genomic sequencing, gene synthesis, laboratory processing services, laboratory analysis, biospecimen procurement services and other support services to scientific research and support drug development.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
12,975 |
| Total Buy Value |
$0 |
$0 |
$0 |
$752,191 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
0 |
39,197 |
39,197 |
| Total Sell Value |
$0 |
$0 |
$2,183,306 |
$2,183,306 |
| Total People Sold |
0 |
0 |
2 |
2 |
| Total Sell Transactions |
0 |
0 |
5 |
5 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Liao Guojuan |
President, GENEWIZ |
• – – |
2019-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
4,254 |
12,045 |
|
- |
|
| Jarzynka David |
President, Semi Solutions |
• – – |
2019-11-08 |
4 |
S |
$46.14 |
$2,299,708 |
D/D |
(49,417) |
43,477 |
|
- |
|
| Gray David C |
Chief Strategy & New Business |
• – – |
2019-11-08 |
4 |
S |
$46.76 |
$350,700 |
D/D |
(7,500) |
56,459 |
|
- |
|
| Pietrantoni David |
Principal Accounting Officer |
• – – |
2019-11-07 |
4 |
AS |
$47.00 |
$203,698 |
D/D |
(4,334) |
28,101 |
|
- |
|
| Pietrantoni David |
Principal Accounting Officer |
• – – |
2019-10-28 |
4 |
AS |
$44.00 |
$146,652 |
D/D |
(3,333) |
32,435 |
|
- |
|
| Joseph Jason |
SVP, General Counsel, Secy. |
• – – |
2019-10-24 |
4 |
AS |
$42.50 |
$232,815 |
D/D |
(5,478) |
77,352 |
|
- |
|
| Robertson Lindon G |
EVP & Chief Financial Officer |
• – – |
2019-07-31 |
4 |
A |
$26.22 |
$12,507 |
D/D |
477 |
147,859 |
|
- |
|
| Joseph Jason |
SVP, General Counsel, Secy. |
• – – |
2019-07-31 |
4 |
A |
$26.22 |
$4,431 |
D/D |
169 |
82,830 |
|
- |
|
| Pietrantoni David |
Principal Accounting Officer |
• – – |
2019-07-23 |
4 |
AS |
$41.00 |
$136,653 |
D/D |
(3,333) |
35,768 |
|
- |
|
| Woollacott Alfred III |
Director |
– • – |
2019-05-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
81,736 |
|
- |
|
| Woollacott Alfred III |
Director |
– • – |
2019-05-08 |
4 |
S |
$38.93 |
$169,540 |
D/D |
(4,355) |
84,736 |
|
- |
|
| Joseph Jason |
SVP, General Counsel, Secy. |
• – – |
2019-05-06 |
4 |
AS |
$39.50 |
$118,500 |
D/D |
(3,000) |
82,661 |
|
- |
|
| Jarzynka David |
Sr. VP, General Manager |
• – – |
2019-05-06 |
4 |
S |
$38.95 |
$100,374 |
D/D |
(2,577) |
92,894 |
|
- |
|
| Montone William T. |
SVP, Human Resources |
• – – |
2019-05-02 |
4 |
AS |
$38.06 |
$64,398 |
D/D |
(1,692) |
109,809 |
|
- |
|
| Pietrantoni David |
Principal Accounting Officer |
• – – |
2019-04-30 |
4 |
AS |
$34.01 |
$284,040 |
D/D |
(8,000) |
39,101 |
|
- |
|
| Montone William T. |
SVP, Human Resources |
• – – |
2019-04-30 |
4 |
AS |
$34.10 |
$156,788 |
D/D |
(4,539) |
111,501 |
|
- |
|
| Joseph Jason |
SVP, General Counsel, Secy. |
• – – |
2019-04-01 |
4 |
AS |
$29.81 |
$178,860 |
D/D |
(6,000) |
85,661 |
|
- |
|
| Joseph Jason |
VP, General Counsel, Secretary |
• – – |
2019-02-19 |
4 |
AS |
$33.50 |
$100,500 |
D/D |
(3,000) |
91,014 |
|
- |
|
| Tenney Maurice H. |
President-Brooks Life Sciences |
• – – |
2019-02-15 |
4 |
S |
$32.51 |
$331,732 |
D/D |
(10,204) |
136,556 |
|
- |
|
| Woollacott Alfred III |
Director |
– • – |
2019-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,033 |
89,091 |
|
- |
|
| Zane Ellen M |
Director |
– • – |
2019-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,033 |
49,783 |
|
- |
|
| Palepu Krishna G. |
Director |
– • – |
2019-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,033 |
95,276 |
|
- |
|
| Allen A Clinton |
Director |
– • – |
2019-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,033 |
79,296 |
|
- |
|
| Martin Joseph R |
Director |
– • – |
2019-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,377 |
89,501 |
|
- |
|
| Wrighton Mark S |
Director |
– • – |
2019-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,033 |
106,755 |
|
- |
|
1054 Records found
|
|
Page 11 of 43 |
|
|
0.26 (0.5%) 
